GlassScriptPhysician profile
Gerald James Roper
NPI 1720070642
$33,905.10
in general payments reported to CMS, 2019-2025
19 companies · $2,384 in 2025
The $2,384 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,304 · 2020: $19K · 2021: $3,168 · 2022: $3,528 · 2023: $3,634 · 2024: $242 · 2025: $2,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,260 · Travel and Lodging: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,260.21 |
| Travel and Lodging | $3,000.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $21,421.08 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $6,992.70 | 2021-2025 | Forum, Iolmaster 700, Cirrus Hd-Oct |
| Alcon Vision LLC | $1,845.11 | 2019-2025 | Clareon, Hydrus Microstent, Voyager Dslt |
| Abbvie INC. | $492.14 | 2022-2023 | Durysta |
| Sun Pharmaceutical Industries INC. | $445.49 | 2019-2023 | Cequa, Bromsite, Xelpros |
| Bausch & Lomb Americas INC. | $407.77 | 2022-2024 | Vyzulta, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $397.89 | 2019 | |
| Aerie Pharmaceuticals, INC. | $317.85 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $293.13 | 2022-2023 | Acthar |
| Oyster Point Pharma, INC. | $282.69 | 2022-2023 | Tyrvaya |
| Biotissue Holdings INC. | $219.05 | 2019 | |
| Sight Sciences, INC. | $149.78 | 2021 | |
| Allergan, INC. | $149.68 | 2019 | |
| Carl Zeiss Meditec Cataract Technology INC. | $129.58 | 2019 | |
| Horizon Therapeutics Plc | $125.00 | 2023 | Tepezza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $123.43 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $61.66 | 2019 | |
| Kala Pharmaceuticals, INC. | $28.10 | 2022 | |
| New World Medical,INC. | $22.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Roper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.